THE COMPARISON OF OXIDATIVE STRESS LEVELS BETWEEN E-CIGARETTE SMOKERS AND CONVENTIONAL SMOKERS IN YOUNG ADULT IN SURABAYA

Elisabeth Tri Wahyuni, Helmia Hasan

Abstract


Background: Smoking is one of the leading causes of morbidity and mortality worldwide. Previously, e-cigarettes were considered safe, but later some studies have reported that e-cigarette can increase oxidative stress and induce an inflammatory response. Isoprostane is a biomarker of oxidative stress, which is thought to play a role in the pathogenesis of COPD. The purpose of this study was to determine the level of oxidative stress between e-cigarette and conventional smokers by measuring the isoprostan level in the two group and comparing them. Method: This research is an observational analytic study conducted in Surabaya. Anamnesis, physical examination, chest X-ray, and complete blood were
carried out, followed by urine isoprostane. The research subjects were 28 e-cigarrete smokers, 27 conventional smokers, and 14 controls who never smoked. Urine isoprostane levels were measured by the ELISA method using a random urine sample and then corrected with urine creatinine from the same sample. Differences in urine isoprostane levels in the three groups used the Mann-Whitney test. Result: The statistical analysis results showed no significant difference in urine isoprostane levels between e-cigarette and conventional smokers (p = 0.054). The mean and median of urine isoprostane in e-cigarette and conventional smokers tended to be higher than controls. Conclusion: The levels of urine isoprostane for e-cigarette and conventional smokers tended to be higher than controls, but there was
no statistically significant difference. It can be concluded that the level of oxidative stress in the two groups did not have significant difference but tended to be higher than controls.

Save to Mendeley


Keywords


Oxidative stress; E-cigarette; urine isoprostane; ROS

Full Text:

PDF

References


Shiels MS, Katki HA, Freedman ND, et al. Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst 2014;106(11):1–8.

Kemenkes Republik Indonesia. TEMBAKAU di Indonesia TEMBAKAU di Indonesia [Internet]. 2014. Available from: http://www.depkes.go.id/download.php?file=download/pusdatin/infodatin/inf odatin-hari-tanpa-tembakausedunia.pdf

IAKMI T. Atlas Tembakau Indonesia Tahun 2020. 2020;33.

Drummond MB, Upson D. Electronic cigarettes: Potential harms and benefits. Ann Am Thorac Soc 2014;11(2):236– 242.

Pisinger C. A systematic review of health effects of electronic cigarettes. 2015.

Singh KP, Lawyer G, Muthumalage T, et al. Systemic biomarkers in electronic cigarette users: implications for noninvasive assessment of vapingassociated pulmonary injuries. ERJ Open Res [Internet] 2019;5(4):00182– 02019. Available from: http://dx.doi.org/10.1183/23120541.00 182-2019

Morrow JD, Roberts LJ. The isoprostanes: Their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 2002;166(12 II):25–30.

Carmella SG, Heskin AK, Tang MK, et al. Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation. PLoS One 2019;14(4):1– 15.

BPS. Persentase Merokok Penduduk Pada Umur ≥ 15 Tahun Menurut Kelompok Umur 2015-2018. 2020;3857046.

Elsa, Syahrawani Elsa; Nadjib M. Deter minan rokok e le ktr ik di Indonesia : data SUSENAS ( Survei Sosial Ekonomi Nasional ) tahun 2017. 2019;35(2):41–48.

Helmersson H, Basu S. F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot Essent Fat Acids 1999;61(3):203–205.

Viau C, Lafontaine M, Payan JP. Creatinine normalization in biological monitoring revisited: The case of 1hydroxypyrene. Int Arch Occup Environ Health 2004;77(3):177–185.

Plas A van der, Pouly S, La Bourdonnaye G de, Baker G, Lüdicke F. Influence of smoking on levels of urinary 8-iso Prostaglandin F2α. Toxicol Reports 2019;6(October 2018):18–25.

Graille M, Wild P, Sauvain JJ, Hemmendinger M, Guseva Canu I, Hopf NB. Urinary 8-isoprostane as a biomarker for oxidative stress. A systematic review and meta-analysis. Toxicol Lett [Internet] 2020;328(April):19–27. Available from: https://doi.org/10.1016/j.toxlet.2020.04 .006

Obata T, Tomaru K, Nagakura T, Izumi Y, Kawamoto T. Smoking and oxidant stress: Assay of isoprostane in human urine by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 2000;746(1):11–15.

Sakano N, Takahashi N, Wang DH, et al. Plasma 3-nitrotyrosine, urinary 8isoprostane and 8-OHdG among healthy Japanese people. Free Radic Res 2009;43(2):183–192.

Taito S, Hamada H, Sekikawa K, Kamikawa N, Takahashi M. Oxidative stress in cigarette smokers and patients with chronic obstructive pulmonary disease. Oxid Antioxid Med Sci 2017;6(2):19.

Foronjy, Robert; D’Armiento J. The Effect of Cigarette Smoke-derived Oxidants on the Inflammatory Response of the Lung. Clin Appl Immunol Rev 2006;6(1):53–72.

Son Y, Mishin V, Laskin JD, et al. Hydroxyl Radicals in E-Cigarette Vapor and E-Vapor Oxidative Potentials under Different Vaping Patterns. Chem Res Toxicol 2019;32(6):1087–1095.

Czekala L, Simms L, Stevenson M, Tschierske N, Maione AG, Walele T. Toxicological comparison of cigarette smoke and e-cigarette aerosol using a 3D in vitro human respiratory model. Regul Toxicol Pharmacol [Internet] 2019;103(September 2018):314–324. Available from: https://doi.org/10.1016/j.yrtph.2019.01 .036

Chandra M, Panchatcharam M, Sumitra M. Biomarkers Role of of Isoprostanes

in Oxidative Stess. Free Radicals Dis 2016;131–148.

Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: A magnificent pathway. Journals Gerontol - Ser A Biol Sci Med Sci 2006;61(6):575–584.

Bougoulia M, Triantos A, Koliakos G. Plasma interleukin-6 levels, glutathione peroxidase and isoprostane in obese women before and after weight loss. Association with cardiovascular risk factors. Hormones (Athens) 2006;5(3):192–199.




DOI: https://doi.org/10.33508/jwm.v8i1.4026